“BRI has been found to be superior in estimating risk for clinical endpoints including cardiometabolic disease, kidney ...

Pfizer will produce the drug, which targets lung and colorectal cancers, in the US and take a US$100 million stake in China’s 3SBio.

More than 80 international and regional healthcare experts have convened at the Pfizer MERA Maternal Immunization Summit: ...

Recent findings regarding interferon and Janus kinase inhibition may hold clues to improving outcomes in patients with ...